AGY Therapeutics

Related by string. * Agy . AGYS : Agilysys NASDAQ AGYS . Agilysys AGYS . AGY Holding Corp. . AGY Asia . Inc. Nasdaq AGYS . Ana Agy / THERAPEUTICS . THERAPEUTIC . therapeutics . therapeutic : small molecule therapeutics . Therapeutic Competitors include . Qualifying Therapeutic Discovery . Inc Therapeutic Competitors . Therapeutics . commercializes innovative therapeutics * *

Related by context. Frequent words. (Click for all words.) 68 Regado Biosciences 67 Bayhill Therapeutics 64 NovaBay Pharmaceuticals 64 Inovio Pharmaceuticals 64 Neogenix Oncology 64 Vicor Technologies 64 FzioMed 64 VioQuest Pharmaceuticals 64 Idera Pharmaceuticals 64 Genaera Corporation 64 Urigen Pharmaceuticals Inc. 63 Metabasis Therapeutics Inc. 63 OncoMed Pharmaceuticals 63 Elixir Pharmaceuticals 63 Transcept Pharmaceuticals 63 CardioVascular BioTherapeutics Inc. 63 Emisphere Technologies 63 Cerus Corporation 63 MorphoSys AG FSE MOR 63 lululemon athletica inc 63 Diatos 63 Exploit collaboration 63 Peptimmune 63 BioSpecifics Technologies Corp. 62 Initiates Phase II 62 Inc Therapeutic Competitors 62 VIA Pharmaceuticals 62 AVEO Pharmaceuticals 62 Nastech Pharmaceutical Company 62 Ardea Biosciences 62 TargeGen 62 Amorcyte 62 Lexicon Genetics 62 Synergy Pharmaceuticals 62 Aerovance 62 Pharmion Corporation 62 ARCA biopharma Inc. 62 Calistoga Pharmaceuticals 61 Metabasis Therapeutics 61 Sunesis Pharmaceuticals 61 Sernova Corp. 61 Dynavax Technologies Corporation 61 Crucell NV Euronext 61 Fibrocell Science Inc. 61 Inc. Nasdaq SUPG 61 Omeros Corporation 61 Pervasis 61 EnVivo Pharmaceuticals 61 Archemix Corp. 61 Ciphergen Biosystems Inc. 61 OncoGenex Pharmaceuticals 61 Cyntellect 60 CureDM 60 Flamel Technologies 60 Idenix Pharmaceuticals 60 Aegera 60 Callisto Pharmaceuticals Inc. 60 Halozyme Therapeutics 60 Merrimack Pharmaceuticals 60 Progenics Pharmaceuticals 60 Ambit Biosciences 60 CoTherix Inc. 60 Immunicon Corporation 60 NanoBio Corporation 60 Completes Enrollment 60 Tranzyme Pharma 60 ImmuneRegen BioSciences Inc. 60 Preclinical Development 60 Receives Orphan Drug Designation 60 Portola Pharmaceuticals 60 Vicuron Pharmaceuticals 60 Threshold Pharmaceuticals 60 Nutra Pharma Corporation 60 Alseres Pharmaceuticals Inc. 60 Trubion Pharmaceuticals 59 ChondroGene 59 FoldRx 59 Ceregene 59 Regulus Therapeutics 59 Biosite Incorporated 59 FluoroPharma 59 Pluristem Therapeutics 59 Files Shelf Registration Statement 59 OncoMethylome Sciences 59 Presents Positive 59 OPKO Health 59 NASDAQ LGND 59 MacroPore Biosurgery 59 Lexicon Pharmaceuticals 59 ImmunoCellular Therapeutics 59 Molecular Biometrics 59 Adeona Pharmaceuticals Inc. 59 Cancer Immunotherapy 59 Cyclacel Pharmaceuticals 59 EKR Therapeutics 59 Trius Therapeutics 59 Ariad Pharmaceuticals 59 BioForce Nanosciences 59 Diversa Corporation 59 Celator Pharmaceuticals 59 Coley Pharmaceutical Group

Back to home page